Esperion Therapeutics Eulerpool vesti

Esperion Therapeutics Eulerpool News

Esperion Therapeutics Akcija Vesti

Esperion Therapeutics праћен је од стране многих новинара и инвеститора широм света. Најсвежије Esperion Therapeutics вести окупљамо овде.

• 23. мај ·

  Yahoo
  Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
• 23. мај ·

  Yahoo
  Esperion to Participate in Upcoming June Investor Conferences
• 22. мај ·

  Yahoo
  First-In-Class Cholesterol-Lowering Treatment NILEMDO® (NEXLETOL® in the U.S.) and Its Combination with Ezetimibe, NUSTENDI® (NEXLIZET® in the U.S.), Approved In Europe To Treat Hypercholesterolemia and Significantly Reduce Cardiovascular Risk
• 22. мај ·

  Thefly.com
  Esperion, Daiichi announce EC approved label update for NILEMDO, NUSTENDI
• 20. мај ·

  TipRanks
  Optimistic Outlook for Esperion: Buy Rating Supported by Clinical Success and Market Expansion Potential
• 20. мај ·

  Yahoo
  Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
• 20. мај ·

  Seeking Alpha
  Esperion's late stage trial of high cholesterol treatment met main goal
• 20. мај ·

  SeekingAlpha
  Buy Esperion Therapeutics Despite An Abiding Skepticism Weighing On The Stock
• 20. мај ·

  Thefly.com
  Esperion's bempedoic acid meets primary endpoint in hypercholesterolemia
• 17. мај ·

  Stock Options Channel
  July 19th Options Now Available For Esperion Therapeutics (ESPR)